Clinical Trial Results:
A Randomised, Double-Blind, Placebo- and Active-Controlled,
Incomplete Crossover Efficacy and Safety Comparison of 4-week
Treatment Periods of Once Daily Treatment of 4 Doses of BI 1744 CL
Inhalation Solution Delivered by the Respimat® in Patients with
Asthma
Summary
|
|
EudraCT number |
2009-013395-48 |
Trial protocol |
AT DE SI SK |
Global completion date |
14 Jan 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 May 2016
|
First version publication date |
05 Apr 2015
|
Other versions |
|
Summary report(s) |
1222.27 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.